Skip to main content
CHEMCLIN DIAGNOSTICS CO., LTD. logo

CHEMCLIN DIAGNOSTICS CO., LTD. — Investor Relations & Filings

Ticker · 688468 ISIN · CNE100005311 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 511 across all filing types
Latest filing 2025-04-28 Notice of Dividend Amou…
Country CN China
Listing Shanghai Stock Exchange 688468

About CHEMCLIN DIAGNOSTICS CO., LTD.

https://www.chemclin.com/

CHEMCLIN DIAGNOSTICS CO., LTD. specializes in the research, development, and manufacturing of in vitro diagnostic systems and reagents. The company is primarily recognized for its proprietary Light-initiated Chemiluminescent Assay (LiCA) technology, a homogeneous chemiluminescence platform that eliminates the need for washing steps, thereby enhancing testing efficiency and precision. Its product portfolio includes fully automated immunoassay analyzers and a comprehensive range of diagnostic kits covering infectious diseases, cardiac markers, thyroid function, tumor markers, and reproductive health. By integrating advanced biotechnology with automated instrumentation, the company provides clinical laboratories and medical institutions with high-sensitivity diagnostic solutions designed to improve patient care and laboratory workflow.

Recent filings

Filing Released Lang Actions
科美诊断技术股份有限公司2024年度利润分配方案公告
Notice of Dividend Amount Classification · 95% confidence The document is a formal announcement from the board of directors of 科美诊断技术股份有限公司 regarding the company's 2024 annual profit distribution plan. It details the dividend per share, total dividend amount, and the basis for calculation, including the number of shares and the exclusion of treasury shares. It also mentions the need for shareholder approval at the upcoming annual general meeting. The document includes financial figures audited by an accounting firm and discusses compliance with stock exchange listing rules. The length is about 2500 characters, which is relatively short and the document is primarily an announcement of the dividend distribution plan rather than the full annual report or financial statements. It does not contain comprehensive financial data or detailed financial performance analysis. Therefore, it is best classified as a Notice of Dividend Amount (DIV).
2025-04-28 Chinese
科美诊断技术股份有限公司章程（2025年4月）
Governance Information Classification · 100% confidence The document is titled as the Articles of Association (章程) of 科美诊断技术股份有限公司 (Chemclin Diagnostics Co., Ltd.) dated April 2025. It contains detailed company governance rules, shareholder rights, board structure, share issuance and transfer rules, meeting procedures, and other corporate governance matters. It references relevant laws such as the Company Law of China, Securities Law, and Shanghai Stock Exchange listing rules. The content is a comprehensive governance document outlining the internal rules and structure of the company rather than a financial report, announcement, or meeting material. It is not an Annual Report, Interim Report, Earnings Release, nor a Proxy Statement or Voting Results. It is not a regulatory filing or legal proceeding update. The document fits the definition of Governance Information (CGR) as it details the company's internal rules, board structure, and governance practices.
2025-04-28 Chinese
科美诊断技术股份有限公司独立董事2024年度述职报告（张捷）
Regulatory Filings
2025-04-28 Chinese
科美诊断技术股份有限公司对外投资管理办法（2025年4月）
Governance Information Classification · 95% confidence The document is titled '科美诊断技术股份有限公司对外投资管理办法' which translates to 'Kemei Diagnostic Technology Co., Ltd. External Investment Management Measures'. It is a detailed internal policy document outlining the principles, approval authorities, organizational structure, decision-making processes, personnel management, financial management, and audit procedures related to the company's external investments. There is no indication that this is a financial report, earnings release, regulatory filing, or announcement. It is a governance-related document describing internal rules and procedures for managing external investments. Therefore, it fits best under Governance Information (CGR). The document length is 4342 characters, which is substantial and contains detailed procedural content, not a brief announcement or certification.
2025-04-28 Chinese
科美诊断技术股份有限公司关于续聘2025年度审计机构的公告
Audit Report / Information Classification · 95% confidence The document is an announcement regarding the proposed reappointment of an audit firm (信永中和会计师事务所) for the company's 2025 audit. It details the audit firm's qualifications, independence, and the board and audit committee's approval of the proposal. It explicitly states that the appointment is subject to approval at the 2024 annual shareholders meeting. The document does not contain any financial statements or audit reports themselves, but rather is a notice about the audit firm appointment process. The document length is short (2400 characters) and it is clearly an announcement rather than a full audit report or annual report. Therefore, it fits best into the category of Audit Report / Information (AR) as it relates to audit matters but is not a full annual report or audit report itself. It is not a Regulatory Filing (RNS) because it is a substantive announcement about audit firm appointment, not a mere certification or compliance filing. FY 2025
2025-04-28 Chinese
科美诊断技术股份有限公司2024年度募集资金存放与使用情况的专项报告
Capital/Financing Update Classification · 95% confidence The document is a detailed announcement about the company's fundraising activities, specifically the use and management of funds raised through an initial public offering (IPO). It includes information on the amount raised, usage of funds, regulatory approvals, and compliance with relevant laws and stock exchange rules. It also contains audit opinions on the use of the funds and detailed tables showing the allocation and usage of the raised capital. The document is not a full annual report or interim financial report but a specialized report focused on the management and use of capital raised. This fits the definition of a Capital/Financing Update (CAP), which covers updates on company fundraising and capital structure changes. The document length (6185 characters) and content confirm it is a substantive report, not just an announcement of a report publication or a regulatory filing. Therefore, the correct classification is CAP with high confidence.
2025-04-28 Chinese

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.